Hatakawa, Y.; Tanaka, A.; Furubayashi, T.; Nakamura, R.; Konishi, M.; Akizawa, T.; Sakane, T.
Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration. Pharmaceutics 2021, 13, 1673.
https://doi.org/10.3390/pharmaceutics13101673
AMA Style
Hatakawa Y, Tanaka A, Furubayashi T, Nakamura R, Konishi M, Akizawa T, Sakane T.
Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration. Pharmaceutics. 2021; 13(10):1673.
https://doi.org/10.3390/pharmaceutics13101673
Chicago/Turabian Style
Hatakawa, Yusuke, Akiko Tanaka, Tomoyuki Furubayashi, Rina Nakamura, Motomi Konishi, Toshifumi Akizawa, and Toshiyasu Sakane.
2021. "Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration" Pharmaceutics 13, no. 10: 1673.
https://doi.org/10.3390/pharmaceutics13101673
APA Style
Hatakawa, Y., Tanaka, A., Furubayashi, T., Nakamura, R., Konishi, M., Akizawa, T., & Sakane, T.
(2021). Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration. Pharmaceutics, 13(10), 1673.
https://doi.org/10.3390/pharmaceutics13101673
